Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,087 | -23,167 | -8,517 | -8,990 | N/A |
| Depreciation Amortization | 322 | 214 | 175 | 154 | N/A |
| Other Working Capital | 881 | 62 | 30 | -1,052 | N/A |
| Other Operating Activity | 4,007 | 2,099 | 203 | 128 | 0 |
| Operating Cash Flow | $-29,877 | $-20,792 | $-8,109 | $-9,760 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -607 | -1,110 | -389 | -132 | N/A |
| Purchase Of Investment | -102,255 | -119,244 | 0 | N/A | N/A |
| Sale Of Investment | 123,281 | 36,450 | 0 | N/A | N/A |
| Investing Cash Flow | $20,419 | $-83,904 | $-389 | $-132 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 272 | 77,913 | 0 | 36 | N/A |
| Other Financing Activity | 0 | 0 | 49,755 | 0 | 0 |
| Financing Cash Flow | $272 | $77,913 | $49,755 | $36 | $N/A |
| Exchange Rate Effect | -45 | -81 | 29 | -150 | N/A |
| Beginning Cash Position | 24,182 | 51,046 | 9,760 | 19,766 | N/A |
| End Cash Position | 14,951 | 24,182 | 51,046 | 9,760 | N/A |
| Net Cash Flow | $-9,231 | $-26,864 | $41,286 | $-10,006 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,877 | -20,792 | -8,109 | -9,760 | N/A |
| Capital Expenditure | -607 | -1,120 | -389 | -132 | N/A |
| Free Cash Flow | -30,484 | -21,912 | -8,498 | -9,892 | 0 |